IFITM3 and esophageal squamous cell carcinoma: Combined with findings in this study and our previous studies, we believe that it is indispensible for pN0 ESCC patients with IFITM3 overexpression to receive postoperative adjuvant radiotherapy to control the metastatic recurrence of locoregional lymph nodes and in turn improve the survival.